Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
D0060-319
i
Other names:
D0060-319
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Easton Biopharma
Drug class:
Menin-MLL inhibitor
Related drugs:
‹
revumenib (18)
ziftomenib (13)
BMF-219 (10)
VTP-50469 (5)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
MI-2 (1)
DSP-5336 (1)
revumenib (18)
ziftomenib (13)
BMF-219 (10)
VTP-50469 (5)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
MI-2 (1)
DSP-5336 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MLL rearrangement
Leukemia
MLL rearrangement
Leukemia
D0060-319
Sensitive: D – Preclinical
D0060-319
Sensitive
:
D
D0060-319
Sensitive: D – Preclinical
D0060-319
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.